Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Recognized by America's Top Doctors 2011 - 2018
Recognized by Best Doctors in America 2011 - 2018
Recognized in Philadelphia magazine's annual Top Docs issues, 2011 - 2019
Internal Medicine, 1984
Medical Oncology, 1993
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Brickman Cristina E, Propert Kathleen J, Merlin Jessica S, Liu Jeffrey C, Eady Sequoya, Mcghee-Jez Amy, Ragin Camille, Grover Surbhi, Cohen Roger B, Gross Robert: Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus. AIDS research and human retroviruses : 2019.
Chao Hann-Hsiang, Schonewolf Caitlin A, Tan Erik X, Swisher-McClure Samuel, Ghiam Alireza F, Weinstein Gregory S, O'Malley Bert W, Chalian Ara A, Rassekh Christopher H, Newman Jason G, Cohen Roger B, Bauml Joshua M, Aggarwal Charu, Lin Alexander, Lukens John N: The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation. Head & neck : 2019.
Bauml Joshua M, Mick Rosemarie, Ciunci Christine, Aggarwal Charu, Davis Christiana, Evans Tracey, Deshpande Charuhas, Miller Linda, Patel Pooja, Alley Evan, Knepley Christina, Mutale Faith, Cohen Roger B, Langer Corey J: Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial. JAMA oncology : 2019.
Gatto Nicolle M, Koralek Daniel O, Bracken Michael B, Duggan William T, Lem Joanna, Klioze Sol, Koch Gary G, Wise Robert A, Cohen Roger B, Jackson Neville C: Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-up Study of Patients Enrolled in Exubera-Controlled Clinical Trials (FUSE) Final Results. Diabetes care 42 (9): 1708-1715,2019.
Bagley Stephen J, Talento Suzanna, Mitra Nandita, Meropol Neal J, Cohen Roger B, Langer Corey J, Vachani Anil: Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network : JNCCN 17 (5): 469-477,2019.
Liou Kevin T, Hung Tony K W, Meghani Salimah H, Epstein Andrew S, Li Q Susan, Romero Sally A D, Cohen Roger B, Mao Jun J: What if Acupuncture Were Covered by Insurance for Pain Management? A Cross-Sectional Study of Cancer Patients at One Academic Center and 11 Community Hospitals. Pain medicine (Malden, Mass.) : 2019.
He Aiwu Ruth, Cohen Roger B, Denlinger Crystal S, Sama Ashwin, Birnbaum Ariel, Hwang Jimmy, Sato Takami, Lewis Nancy, Mynderse Michelle, Niland Michele, Giles Jennifer, Wallin Johan, Moser Brian, Zhang Wei, Walgren Richard, Plimack Elizabeth R: First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. The oncologist : 2019.
Bauml Joshua M, Vinnakota Ravi, Anna Park Yeun-Hee, Bates Susan E, Fojo Tito, Aggarwal Charu, Di Stefano Jessica, Knepley Christina, Limaye Sewanti, Mamtani Ronac, Wisnivesky Juan, Damjanov Nevena, Langer Corey J, Cohen Roger B, Sigel Keith: Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data. Cancer 125 (3): 406-415,2019.
Bange Erin, Marmarelis Melina E, Hwang Wei-Ting, Yang Yu-Xiao, Thompson Jeffrey C, Rosenbaum Jason, Bauml Joshua M, Ciunci Christine, Alley Evan W, Cohen Roger B, Langer Corey J, Carpenter Erica, Aggarwal Charu: Impact of and Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With -Mutated Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 3 : 2019.
Swed Brandon L, Cohen Roger B, Aggarwal Charu: Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience. JCO precision oncology 3 : 2019.
Division of Hematology-OncologyPerelman Center for Advanced Medicine 10th Floor, South PavilionOffice #10-139
Phone: (215) 662-4469
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.